Siemens Healthineers AG Income Statement

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	23,375	22,363	21,680	21,714	17,997
Revenue Growth (YoY)	4.52%	3.15%	-0.16%	20.65%	24.46%
Cost of Revenue	14,345	13,895	13,971	13,577	11,045
Gross Profit	9,030	8,468	7,709	8,137	6,952
Selling, General & Admin	3,887	3,681	3,607	3,408	2,817
Research & Development	1,958	1,918	1,866	1,785	1,546
Other Operating Expenses	21	60	103	20	21
Operating Expenses	5,866	5,659	5,576	5,213	4,384
Operating Income	3,164	2,809	2,133	2,924	2,568
Interest Expense	-425	-476	-296	-118	-83
Interest & Investment Income	99	119	85	48	33
Earnings From Equity Investments	-10	-2	3	2	5
Currency Exchange Gain (Loss)	328	564	1,198	-2,022	-273
Other Non Operating Income (Expenses)	-303	-491	-1,195	1,967	153
EBT Excluding Unusual Items	2,853	2,523	1,928	2,801	2,403
Pretax Income	2,853	2,523	1,928	2,801	2,403
Income Tax Expense	686	564	403	746	658
Earnings From Continuing Operations	2,167	1,959	1,525	2,055	1,745
Minority Interest in Earnings	-23	-17	-16	-17	-18
Net Income	2,144	1,942	1,509	2,038	1,727
Net Income to Common	2,144	1,942	1,509	2,038	1,727
Net Income Growth	10.40%	28.69%	-25.96%	18.01%	22.39%
Shares Outstanding (Basic)	1,120	1,118	1,119	1,123	1,100
Shares Outstanding (Diluted)	1,125	1,123	1,124	1,128	1,104
Shares Change (YoY)	0.11%	-0.01%	-0.37%	2.19%	9.91%
EPS (Basic)	1.91	1.74	1.35	1.82	1.57
EPS (Diluted)	1.91	1.73	1.34	1.81	1.57
EPS Growth	10.41%	29.10%	-25.97%	15.29%	12.14%
Free Cash Flow	2,714	2,130	1,281	1,652	2,259
Free Cash Flow Per Share	2.41	1.90	1.14	1.47	2.05
Dividend Per Share	1.000	0.950	0.950	0.950	0.850
Dividend Growth	5.26%	-	-	11.77%	6.25%
Gross Margin	38.63%	37.87%	35.56%	37.47%	38.63%
Operating Margin	13.54%	12.56%	9.84%	13.47%	14.27%
Profit Margin	9.17%	8.68%	6.96%	9.39%	9.60%
Free Cash Flow Margin	11.61%	9.53%	5.91%	7.61%	12.55%
EBITDA	4,074	3,736	3,229	3,941	3,307
EBITDA Margin	17.43%	16.71%	14.89%	18.15%	18.38%
D&A For EBITDA	910	927	1,096	1,017	739
EBIT	3,164	2,809	2,133	2,924	2,568
EBIT Margin	13.54%	12.56%	9.84%	13.47%	14.27%
Effective Tax Rate	24.04%	22.35%	20.90%	26.63%	27.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.